Amyloid Scans Increase Treatment Rate After Inconclusive PET

June 24, 2015

In patients with indeterminate traditional fluorodeoxyglucose (FDG)-PET scans, early amyloid PET could lead to earlier treatment, and the preservation of cognitive function, in up to one-sixth of patients, new research suggests.

"As of now, Medicare is not paying for amyloid scans; therefore, physicians are not regularly referring patients for these studies," lead researcher Erica Parker, a medical student at the University of California, Los Angeles, told Medscape Medical News.

Read the full story.